NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Since those rumors made the rounds, Samsung has confirmed to Android Authority that a new S Pen isn’t coming, and that the page will be edited. Samsung confirmed that these features were removed ...

After years of court battles, the daughter-in-law of founder Marcel Bich, who perfected the ballpoint pen and launched French ... litigating,” they said in a new Manhattan Supreme Court filing.

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

All you have to follow the instructions given by your healthcare provider. Read the guide that comes with your Ozempic pen, you can also watch videos or attend training sessions if available to learn ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like nausea and diarrhea. But new research confirms that more serious ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may pose heightened risks for kidney, pancreatic, and gastrointestinal problems.

Few drugs have captured public attention like Ozempic; many of us have even taken ... there’s potential in new medications that incorporate more than one receptor agonist.

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%. Novo Nordisk said a Phase 1b/2a clinical trial of amycretin ...